# A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone

> **NCT03211052** · PHASE2 · TERMINATED · sponsor: **Centre of Experimental Medicine** · enrollment: 16 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** TAK-700 and LHRH agonist
- **PROCEDURE:** prostatectomy

## Key facts

- **NCT ID:** NCT03211052
- **Lead sponsor:** Centre of Experimental Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02-18
- **Primary completion:** 2015-06-02
- **Final completion:** 2015-06-02
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** IMP no longer available
- **Last updated:** 2017-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03211052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03211052, "A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03211052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*